Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Hair regrowth improved, but quality of life did not.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Alefacept does not effectively treat severe alopecia areata.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Elderly patients frequently suffer from skin conditions, especially inflammatory ones, highlighting the need for better healthcare.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.

Ritlecitinib is effective and safe for treating alopecia areata, especially in newer cases.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.